Therapeutics and Clinical Risk Management

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Assessment and Management of Cardiovascular Risk", organized by Guest Advisor Prof. Dr. Yong Peng in Therapeutics and Clinical Risk Management. 

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, necessitating a comprehensive understanding of cardiovascular risk factors and the development of effective prevention and management strategies. This Article Collection aims to explore the multifaceted nature of cardiovascular risk, encompassing traditional factors such as hypertension, dyslipidemia, and diabetes, alongside emerging risk factors, including inflammatory markers, genetic predispositions, and lifestyle influences. The goal is to highlight innovative approaches to risk assessment, early detection, and tailored therapeutic strategies that can optimize cardiovascular health outcomes. 

Addressing cardiovascular risk is critical due to its profound impact on global health and healthcare systems. Despite advances in pharmacotherapy and clinical guidelines, cardiovascular events remain prevalent, with a substantial proportion occurring in individuals who would not traditionally be classified as high-risk. This gap underscores the importance of refining our current risk stratification methods and integrating novel biomarkers and personalized approaches into clinical practice. By understanding the complexities of cardiovascular risk, healthcare professionals can develop more effective strategies to reduce the burden of CVD, improve patient outcomes, and allocate healthcare resources more efficiently. 

The Collection welcomes original research, comprehensive reviews, and clinical studies that delve into the assessment and management of cardiovascular risk. Potential topics include, but are not limited to, novel risk prediction models, the role of imaging in risk stratification, pharmacological and non-pharmacological interventions, and strategies for managing high-risk populations. Manuscripts discussing the implementation of precision medicine approaches and health policy considerations in cardiovascular risk management are also encouraged. We invite contributions that will contribute to advancing our understanding of cardiovascular risk and provide insights for clinical application. 

All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

Keywords

• Cardiovascular Risk Assessment
• Risk Stratification
• Cardiovascular Disease Prevention
• Precision Medicine
• Therapeutic Interventions

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code RMNJP for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.

The deadline for submitting manuscripts is 31 July 2025.

Guest Advisor

Prof. Dr. Yong Peng, Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China

[email protected]

Prof. Peng Yong, MD, FESC, is the Senior Consultant Cardiologist and the Vice Director of the Department of Cardiology at West China Hospital, Sichuan University. As an accomplished interventional cardiologist, Prof. Peng’s expertise spans the interventional treatment and prognosis research of coronary artery disease, valvular heart disease interventions, and sympathetic denervation for hypertension. His clinical and research work aims to advance minimally invasive cardiovascular therapies and improve patient outcomes. Prof. Peng is recognized for his contributions to both clinical practice and academic research in cardiovascular medicine.

View all papers in this article collection

We are pleased to announce a new Article Collection in Therapeutics and Clinical Risk Management, dedicated to the role of biologic treatments in the management of allergic disease. Since their clinical introduction, biologic treatments, particularly monoclonal antibodies, have transformed patient care, offering targeted therapies and improved outcomes for conditions including allergic asthma, allergic rhinitis, atopic dermatitis and urticaria.

Given the importance of biologics in managing allergic disease, we are welcoming submissions of original research articles, reviews, and perspectives exploring the mechanisms of action, clinical efficacy, safety, and real-world application of these therapies.

The Collection, edited by the Editor-In-Chief Prof. Garry Walsh, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

While the call is open to receive manuscripts across the broad spectrum of biologic treatments in allergic disease, the Editors are particularly interested in manuscripts relating to the following areas:
• Mechanisms of action and biomarkers for personalized treatment
• Clinical efficacy and safety profiles
• Real-world evidence and patient-reported outcomes
• Cost-effectiveness and health economic evaluations
• Reviews, perspectives and editorials discussing emerging therapies and future directions

All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 7A889 to indicate that your submission is for consideration in this Article Collection.

The deadline for submitting manuscripts is 1 April 2026.

If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor, Catherine Teng at [email protected].

View all papers in this article collection